Patients with HIV who receive counseling about risk-reduction behaviors in the form of an interactive video are less likely to participate in behaviors that may spread the infection or worsen their own condition, according to results from a randomized controlled trial funded by the National Institute on Drug Abuse.
A team of California researchers recruited participants for the trial from 5 outpatient HIV clinics in the San Francisco Bay area (Gilbert P et al. PLoS ONE. 2008;3[4]:e1988). All patients underwent screening for risky behaviors using a computer program on a laptop. Those who were randomized to the intervention also watched an interactive video of an actor portraying a physician counseling them on reducing risky behaviors such as illicit drug use, excessive alcohol use, and unprotected sex. The counseling used the principles of motivational interviewing, a nonconfrontational approach which taps into a patient's concerns about his or her risky behavior as a means to encourage changes in that behavior.
Individuals who received the intervention were significantly less likely to report ongoing drug use than controls at 3 months (67% vs 82%) and 6 months (56% vs 86%). They also reported significantly less unprotected intercourse than controls at 6 months (62% vs 77%) but not at 3 months. However, there was no difference between the groups for excessive alcohol use.
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
Users' Guides to the Medical Literature For example, a trial of intravenous immunoglobulin in advanced human immunodeficiency infection...
The Rational Clinical Examination Evidence Summary and Review 3
All results at JAMAevidence.com >
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.